{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:01:44Z","timestamp":1789153304630,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970804"],"award-info":[{"award-number":["81970804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770691"],"award-info":[{"award-number":["81770691"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170759"],"award-info":[{"award-number":["82170759"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110418","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T08:56:48Z","timestamp":1686128208000},"page":"110418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases"],"prefix":"10.1016","volume":"121","author":[{"given":"Huihui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1575-7340","authenticated-orcid":false,"given":"Guochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110418_b0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2023.110418_b0010","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110418_b0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41422-020-0277-x","article-title":"The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity","volume":"30","author":"Schnell","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2023.110418_b0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni988","article-title":"Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance","volume":"4","author":"Sabatos","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0030","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","article-title":"Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity","volume":"120","author":"McMahan","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110418_b0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni987","article-title":"Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance","volume":"4","author":"Sanchez-Fueyo","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110418_b0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells","volume":"318","author":"Anderson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110418_b0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","article-title":"T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B","volume":"52","author":"Ju","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2023.110418_b0055","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1182\/blood-2006-11-058800","article-title":"TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells","volume":"110","author":"Nakae","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.110418_b0060","doi-asserted-by":"crossref","first-page":"798683","DOI":"10.3389\/fimmu.2021.798683","article-title":"An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0070","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.2871","article-title":"Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion","volume":"18","author":"Rangachari","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110418_b0075","doi-asserted-by":"crossref","first-page":"101302","DOI":"10.1016\/j.smim.2019.101302","article-title":"Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance","volume":"42","author":"Tang","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0080","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1073\/pnas.1712107115","article-title":"Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion","volume":"115","author":"Avery","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2023.110418_b0085","first-page":"7","article-title":"Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion","author":"Zhu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2023.110418_b0090","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4049\/jimmunol.1302663","article-title":"T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases","volume":"192","author":"Clayton","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2016.00229","article-title":"TIM-3 Regulates Distinct Functions in Macrophages","volume":"7","author":"Oca\u00f1a-Guzman","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0100","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.2871","article-title":"Bat3 promotes T cell responses and autoimmunity by repressing Tim-3\u2013mediated cell death and exhaustion","volume":"18","author":"Rangachari","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110418_b0105","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1128\/MCB.01983-06","article-title":"PAG-associated FynT regulates calcium signaling and promotes anergy in T lymphocytes","volume":"27","author":"Davidson","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.110418_b0110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1189\/jlb.72.3.486","article-title":"Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells","volume":"72","author":"Imaizumi","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2023.110418_b0115","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.4049\/jimmunol.169.10.5912","article-title":"Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9","volume":"169","author":"Asakura","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molimm.2013.11.001","article-title":"The Tim-3\/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis","volume":"58","author":"Ju","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0125","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.0903275","article-title":"Tim-3\/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells","volume":"185","author":"Dardalhon","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0130","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1084\/jem.20100687","article-title":"Tim3 binding to galectin-9 stimulates antimicrobial immunity","volume":"207","author":"Jayaraman","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110418_b0135","doi-asserted-by":"crossref","first-page":"39888","DOI":"10.1074\/jbc.M110.128348","article-title":"High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity","volume":"285","author":"Evankovich","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.110418_b0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110418_b0145","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0150","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.26938","article-title":"Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice","volume":"59","author":"Dolina","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2023.110418_b0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1009650917818","article-title":"Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved","volume":"3","author":"van den Eijnde","year":"1998","journal-title":"Apoptosis: Int. J. Programmed Cell Death"},{"key":"10.1016\/j.intimp.2023.110418_b0160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.0105-2896.2010.00903.x","article-title":"TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity","volume":"235","author":"Freeman","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110418_b0165","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4049\/jimmunol.0903059","article-title":"T cell\/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells","volume":"184","author":"DeKruyff","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0170","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1042\/BCJ20210425","article-title":"Phosphatidylserine binding directly regulates TIM-3 function","volume":"478","author":"Smith","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2023.110418_b0175","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/0008-5472.CAN-19-2332","article-title":"Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling","volume":"80","author":"Tan","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2023.110418_b0180","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1189\/jlb.3HI0117-005RR","article-title":"Frontline Science: Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE","volume":"102","author":"Zhao","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2023.110418_b0185","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2008-10-185884","article-title":"Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation","volume":"113","author":"Nakayama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.110418_b0190","doi-asserted-by":"crossref","first-page":"101296","DOI":"10.1016\/j.smim.2019.101296","article-title":"CEACAM1 structure and function in immunity and its therapeutic implications","volume":"42","author":"Kim","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0195","doi-asserted-by":"crossref","first-page":"29654","DOI":"10.1074\/jbc.M113.504639","article-title":"Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties","volume":"288","author":"Patel","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.110418_b0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110418_b0205","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2023.110418_b0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-3083.2007.02038.x","article-title":"Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients","volume":"67","author":"Wang","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0215","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00403-016-1665-4","article-title":"Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus","volume":"308","author":"Jiao","year":"2016","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.intimp.2023.110418_b0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10238-021-00726-8","article-title":"Increased TIM-3(+)PD-1(+) NK cells are associated with the disease activity and severity of systemic lupus erythematosus","volume":"22","author":"Luo","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110418_b0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13000-015-0306-0","article-title":"Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus","volume":"10","author":"Song","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.intimp.2023.110418_b0230","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10238-013-0264-3","article-title":"Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients","volume":"14","author":"Guo","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110418_b0235","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.4049\/jimmunol.170.7.3631","article-title":"Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway","volume":"170","author":"Kashio","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0240","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160025","article-title":"mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection","volume":"133","author":"Ando","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110418_b0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110418_b0250","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.00006-15","article-title":"Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression","volume":"89","author":"Clayton","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2023.110418_b0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/08916934.2021.1891535","article-title":"Elevated soluble Tim-3 correlates with disease activity of systemic lupus erythematosus","volume":"54","author":"Zhao","year":"2021","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2023.110418_b0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2023.110418_b0265","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1474-4422(14)70041-9","article-title":"Multiple sclerosis genetics","volume":"13","author":"Sawcer","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2023.110418_b0270","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaneurol.2014.395","article-title":"Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers","volume":"71","author":"Alvermann","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2023.110418_b0275","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-065X.2012.01136.x","article-title":"Immune checkpoints in central nervous system autoimmunity","volume":"248","author":"Joller","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110418_b0280","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2019.00835","article-title":"Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis","volume":"10","author":"Lavon","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0285","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.172.11.7169","article-title":"T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis","volume":"172","author":"Khademi","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0290","doi-asserted-by":"crossref","first-page":"577061","DOI":"10.1016\/j.jneuroim.2019.577061","article-title":"The role of immune regulatory molecules in multiple sclerosis","volume":"337","author":"Afshar","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2023.110418_b0295","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.20060210","article-title":"Dysregulated T cell expression of TIM3 in multiple sclerosis","volume":"203","author":"Koguchi","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110418_b0300","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.4049\/jimmunol.180.7.4409","article-title":"Lack of TIM-3 immunoregulation in multiple sclerosis","volume":"180","author":"Yang","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0305","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1096\/fj.14-258194","article-title":"A role for the TIM-3\/GAL-9\/BAT3 pathway in determining the clinical phenotype of multiple sclerosis","volume":"28","author":"Saresella","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2023.110418_b0310","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4049\/jimmunol.1801625","article-title":"A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis","volume":"203","author":"Piancone","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0315","doi-asserted-by":"crossref","first-page":"29847","DOI":"10.1038\/srep29847","article-title":"CEACAM1 mediates B cell aggregation in central nervous system autoimmunity","volume":"6","author":"Rovituso","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.110418_b0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0325","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrrheum.2009.80","article-title":"Type 17 T helper cells-origins, features and possible roles in rheumatic disease","volume":"5","author":"Annunziato","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110418_b0330","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/03009742.2010.547871","article-title":"Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis","volume":"40","author":"Lee","year":"2011","journal-title":"Scand J. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110418_b0335","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clim.2010.07.012","article-title":"Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity","volume":"137","author":"Liu","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0340","first-page":"34","article-title":"T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammation","volume":"11","author":"Skejoe","year":"2022","journal-title":"Am. J. Clin. Exper. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0345","doi-asserted-by":"crossref","first-page":"e0260254","DOI":"10.1371\/journal.pone.0260254","article-title":"Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis","volume":"16","author":"Matsumoto","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110418_b0350","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41390-021-01588-2","article-title":"Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes","volume":"90","author":"Sag","year":"2021","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.intimp.2023.110418_b0355","doi-asserted-by":"crossref","first-page":"e22892","DOI":"10.1097\/MD.0000000000022892","article-title":"T cell immunoglobulin and mucin domain-3 is associated with disease activity and progressive joint damage in rheumatoid arthritis patients","volume":"99","author":"Matsumoto","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.intimp.2023.110418_b0360","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14728222.2012.726616","article-title":"T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis","volume":"16","author":"Li","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2023.110418_b0365","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s10753-017-0577-6","article-title":"Tim3(+) Foxp3 (+) Treg Cells Are Potent Inhibitors of Effector T Cells and Are Suppressed in Rheumatoid Arthritis","volume":"40","author":"Sun","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2023.110418_b0370","doi-asserted-by":"crossref","first-page":"978435","DOI":"10.3389\/fimmu.2022.978435","article-title":"Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis","volume":"13","author":"Matsumoto","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0375","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clim.2012.09.001","article-title":"Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis","volume":"145","author":"Shi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0380","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2018.12.043","article-title":"Fecal bacteria from ulcerative colitis patients downregulate Tim-3-mediated inhibitory effects on monocytes in vitro","volume":"128","author":"Wang","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2023.110418_b0385","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clim.2015.07.008","article-title":"Tim-3 promotes intestinal homeostasis in DSS colitis by inhibiting M1 polarization of macrophages","volume":"160","author":"Jiang","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2009.09.012","article-title":"Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease","volume":"134","author":"Li","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0395","first-page":"370","article-title":"Expression of TIM-3, Human beta-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy","volume":"9","author":"Kim","year":"2015","journal-title":"Gut and liver"},{"key":"10.1016\/j.intimp.2023.110418_b0400","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/00365521.2011.568518","article-title":"Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease","volume":"46","author":"Morimoto","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2023.110418_b0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2013.06.008","article-title":"Using EAE to better understand principles of immune function and autoimmune pathology","volume":"45","author":"Rangachari","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.110418_b0410","doi-asserted-by":"crossref","first-page":"770402","DOI":"10.3389\/fimmu.2021.770402","article-title":"Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0415","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.1300083","article-title":"The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells","volume":"190","author":"Lee","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0420","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0194599818774560","article-title":"TIM-3-Expressing Mast Cells Are Present in Chronic Rhinosinusitis with Nasal Polyps","volume":"159","author":"Corredera","year":"2018","journal-title":"Otolaryngol.\u2013Head Neck Surg.: Offic. J. Am. Acad. Otolaryngol.-Head Neck Surg."},{"key":"10.1016\/j.intimp.2023.110418_b0425","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jdv.16780","article-title":"Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris","volume":"35","author":"Ernst","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol. : JEADV"},{"issue":"Suppl 129","key":"10.1016\/j.intimp.2023.110418_b0430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.55563\/clinexprheumatol\/6y0bjb","article-title":"TIM-3 regulates the NETs-mediated dendritic cell activation in myeloperoxidase-ANCA-associated vasculitis","volume":"39","author":"Su","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110418_b0435","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/2211-5463.13148","article-title":"Tim-3 suppresses autoimmune hepatitis via the p38\/MKP-1 pathway in Th17 cells","volume":"11","author":"Wu","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.intimp.2023.110418_b0440","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-019-0079-0","article-title":"Targeting cell signaling in allergic asthma","volume":"4","author":"Athari","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2023.110418_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156171","article-title":"HMGB1 is a promising therapeutic target for asthma","volume":"165","author":"Zhao","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2023.110418_b0450","doi-asserted-by":"crossref","first-page":"e0249605","DOI":"10.1371\/journal.pone.0249605","article-title":"Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma","volume":"16","author":"Boehne","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110418_b0455","first-page":"517","article-title":"Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma","volume":"17","author":"Mosayebian","year":"2018","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0460","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.alit.2016.04.008","article-title":"TIM-3 is not essential for development of airway inflammation induced by house dust mite antigens","volume":"65","author":"Hiraishi","year":"2016","journal-title":"Allergol. Int. : Offic. J. Japan. Soc. Allergol."},{"key":"10.1016\/j.intimp.2023.110418_b0465","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10753-012-9580-0","article-title":"Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness","volume":"36","author":"Lu","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2023.110418_b0470","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110418_b0475","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110418_b0480","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110418_b0485","article-title":"Activation of CD3+TIM3+ T Cells Contributes to Excessive Inflammatory Response During Glucocorticoid Treatment","author":"Liu","year":"2023","journal-title":"Biochem. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:10:30Z","timestamp":1777619430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923007415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":97,"alternative-id":["S1567576923007415"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110418","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110418"}}